ERAS vs PCVX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

ERAS

45.1
AI Score
VS
ERAS Wins

PCVX

41.5
AI Score

Investment Advisor Scores

ERAS

45score
Recommendation
HOLD

PCVX

42score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ERAS PCVX Winner
Net Income -227.52M -604.92M ERAS
Operating Income -235.53M -648.63M ERAS
ROE -62.9% -21.9% PCVX
ROA -52.3% -19.3% PCVX
Total Assets 435.05M 3.14B PCVX
Cash 42.54M 183.19M PCVX
Current Ratio 8.29 5.72 ERAS
Free Cash Flow -54.70M -519.52M ERAS

Relative Price Performance (Last 90 Days)

ERAS 1M: +0.7% · 3M: -26.5% PCVX 1M: +11.2% · 3M: +15.0%

Current Technical Phase

ERAS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -9.3%), weak momentum, RSI 43

RSI (14): 42.7 · Price: $14.04

PCVX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 49.2 · Price: $62.85

Fundamentals Snapshot

Metric ERAS PCVX
Market Cap — —
Forward P/E -22.5 -8.8
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin — —
Operating Margin 0.0% 0.0%
EPS -0.95 -7.62
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ERAS is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.